Typescript letter, written on Lilly Research Laboratories letterhead and signed by G. H. A. Clowes. Letter includes enclosures of a pamphlet and a post card. Clowes alerts Hutchison and the Insulin Committee to the claims of the Phila. Capsule Co. and the Lafayette Pharmacal Co., two companies manufacturing insulin preparations to be administered orally.